Harnessing the Benefits of Endogenous Hydrogen Sulfide to Reduce Cardiovascular Disease
Cardiovascular disease is the leading cause of death in the U.S. While various studies have shown the beneficial impact of exogenous hydrogen sulfide (H<sub>2</sub>S)-releasing drugs, few have demonstrated the influence of endogenous H<sub>2</sub>S production. Modulating the...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-03-01
|
| Series: | Antioxidants |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3921/10/3/383 |